Literature DB >> 15682443

MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.

Hongtao Ye1, Liping Gong, Hongxiang Liu, Rifat A Hamoudi, Sima Shirali, Liza Ho, Andreas Chott, Berthold Streubel, Reiner Siebert, Stefan Gesk, Jose I Martin-Subero, John A Radford, Sankar Banerjee, Andrew G Nicholson, Renzo Ranaldi, Ellen D Remstein, Zifen Gao, Jie Zheng, Peter G Isaacson, Ahmet Dogan, Ming-Qing Du.   

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is specifically associated with t(11;18)(q21;q21), t(1;14)(p22;q32) and t(14;18)(q32;q21). t(11;18)(q21;q21) fuses the N-terminus of the API2 gene to the C-terminus of the MALT1 gene and generates a functional API2-MALT1 product. t(1;14)(p22;q32) and t(14;18)(q32;q21) bring the BCL10 and MALT1 genes respectively to the IGH locus and deregulate their expression. The oncogenic activity of the three chromosomal translocations is linked by the physiological role of BCL10 and MALT1 in antigen receptor-mediated NFkappaB activation. In this study, MALT1 and BCL10 expression was examined in normal lymphoid tissues and 423 cases of MALT lymphoma from eight sites, and their expression was correlated with the above translocations, which were detected by molecular and molecular cytogenetic methods. In normal B-cell follicles, both MALT1 and BCL10 were expressed predominantly in the cytoplasm, high in centroblasts, moderate in centrocytes and weak/negative in mantle zone B-cells. In MALT lymphoma, MALT1 and BCL10 expression varied among cases with different chromosomal translocations. In 9/9 MALT lymphomas with t(14;18)(q32;q21), tumour cells showed strong homogeneous cytoplasmic expression of both MALT1 and BCL10. In 12/12 cases with evidence of t(1;14)(p22;q32) or variants, tumour cells expressed MALT1 weakly in the cytoplasm but BCL10 strongly in the nuclei. In all 67 MALT lymphomas with t(11;18)(q21;q21), tumour cells expressed weak cytoplasmic MALT1 and moderate nuclear BCL10. In MALT lymphomas without the above translocations, both MALT1 and BCL10, in general, were expressed weakly in the cytoplasm. Real-time quantitative RT-PCR showed a good correlation between MALT1 and BCL10 mRNA expression and underlining genetic changes, with t(14;18)(q32;q21)- and t(1;14)(p22;q32)-positive cases displaying the highest MALT1 and BCL10 mRNA expression respectively. These results show that MALT1 expression pattern is identical to that of BCL10 in normal lymphoid tissues but varies in MALT lymphomas, with high cytoplasmic expression of both MALT1 and BCL10 characterizing those with t(14;18)(q32;q21).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682443     DOI: 10.1002/path.1715

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

Review 1.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas.

Authors:  Shimin Hu; Ming-Qing Du; Sun-Mi Park; Allison Alcivar; Like Qu; Sanjeev Gupta; Jun Tang; Mathijs Baens; Hongtao Ye; Tae H Lee; Peter Marynen; James L Riley; Xiaolu Yang
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication.

Authors:  H Ye; L Gong; H Liu; A Ruskone-Fourmestraux; D de Jong; S Pileri; C Thiede; A Lavergne; H Boot; G Caletti; T Wündisch; T Molina; B G Taal; S Elena; A Neubauer; K A Maclennan; R Siebert; E D Remstein; A Dogan; M-Q Du
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

4.  Delving deeper into MALT lymphoma biology.

Authors:  Francesco Bertoni; Emanuele Zucca
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 5.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

6.  Gastric MALT lymphoma with t(14;18)(q32;q21) involving IGH and BCL2 genes that responded to Helicobacter pylori eradication.

Authors:  Shotaro Nakamura; Hongtao Ye; Chris M Bacon; Hongxiang Liu; Alison Goatly; Takayuki Matsumoto; Hideki Koga; Junji Umeno; Yutaka Ohji; Takashi Yao; Tsukasa Nakahara; Mitsuo Iida; Ming-Qing Du
Journal:  J Clin Pathol       Date:  2007-10       Impact factor: 3.411

7.  Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.

Authors:  Ariz Akhter; Noraidah Masir; Ghaleb Elyamany; Kean-Chang Phang; Etienne Mahe; Ali Matar Al-Zahrani; Meer-Taher Shabani-Rad; Douglas Allan Stewart; Adnan Mansoor
Journal:  J Neurooncol       Date:  2014-11-13       Impact factor: 4.130

8.  Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.

Authors:  Sally Yepes; Maria Mercedes Torres; Carlos Saavedra; Rafael Andrade
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 9.  Newer developments in immunohistology.

Authors:  A S-Y Leong; T Y-M Leong
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

10.  Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.

Authors:  Michelle A Favila; Nicholas S Geraci; Erliang Zeng; Brent Harker; David Condon; Rachel N Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.